The first civil trial against an opioid manufacturer, Johnson & Johnson, has ended in Oklahoma. The verdict could affect lawsuits filed by other local and state governments coping with addiction.
A Triad doctor is headed to trial this week on charges of running an illegal pill mill in Virginia.
The maker of OxyContin will pay to settle a historic opioid lawsuit brought by the attorney general of Oklahoma. Will other drugmakers named in the lawsuit follow?
Critics, including some leading anesthesiologists, say the drug is unnecessary, and they worry it will be diverted and abused. The Food And Drug Administration says it is addressing safety concerns.
This medicine to treat opioid addiction is hard to come by — only a fraction of doctors can prescribe it. So some people trying to quit a heroin habit are turning to the black market for help.
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
States are passing laws that limit a doctor's ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain
Economists tracking federal mortality data say the opioid crisis is undercutting the productivity of people in their prime working years — 30s and 40s.